Please try another search
Wai Chun Bio-Technology Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was HKD 405.08 million compared to HKD 287.87 million a year ago. Net loss was HKD 7.83 million compared to HKD 4.47 million a year ago. Basic loss per share from continuing operations was HKD 0.047 compared to HKD 0.027 a year ago.
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 202.54 | 207.5 | 287.87 | |
Gross Profit | 13.35 | 8.83 | 28.74 | |
Operating Income | 2.32 | -7.52 | 9.15 | |
Net Income | -3.92 | -12.55 | -4.47 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 283.28 | 283.28 | 186.34 | 208.16 |
Total Liabilities | 285.46 | 239.92 | 249.56 | |
Total Equity | -2.17 | -2.17 | -53.58 | -41.4 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -9.4 | -4.66 | ||
Cash From Investing Activities | -0.28 | -0.21 | ||
Cash From Financing Activities | 5.6 | 0.26 | ||
Net Change in Cash | -0.8 | -1.32 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review